Our CD4+CD25+CD127low UCB-Treg cells were able to overcome the inhibitory effect of IFN-γ, which may additionally contribute to its multi-dimensional mechanism of action as a therapeutic agent for SLE patients. This evidence concerns the gene IFNG and systemic lupus erythematosus.